tiprankstipranks
The Fly

Vanda Pharmaceuticals narrows 2024 revenue view to $190M-$210M from $180M-$210M

Vanda Pharmaceuticals narrows 2024 revenue view to $190M-$210M from $180M-$210M

Consensus for 2024 revenue is $198.33M. Narrows 2024 cash guidance to $370M-$390M from $360M-$390M.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Questions or Comments about the article? Write to editor@tipranks.com